Patents Examined by Kristie L Brooks
  • Patent number: 7910755
    Abstract: The invention relates to methods to prevent, treat, ameliorate or slow the progression of one or more of a blood cell deficiency, unwanted inflammation, allergy, immune suppression condition, immunosenescence, autoimmune disorder, infection, neurological disorder, cardiovascular disorder, pulmonary disorder, trauma, hemorrhage, bone fracture or unwanted or excess bone loss with steroid compounds containing carbon-carbon double bonds within the fused four-ring system such that the steroid compounds are unsaturated. The unsaturated steroid compounds include 3,16?,17?-trihydroxy-7-acetoxy-androst-1,3,5(10),6-tetraene, 3,16?,17?-trihydroxy-7-methoxy-androst-1,3,5(10),6-tetraene, 3,17?-dihydroxy-7-acetoxy-16?-fluoro-androst-1,3,5(10),6-tetraene, 3,17?-dihydroxy-7-methoxy-16?-fluoro-androst-1,3,5(10),6-tetraene, 3,17?-dihydroxy-7,16?-diacetoxy-androst-1,3,5(10),6-tetraene and 3,17?-dihydroxy-7-methoxy-16?-acetoxy-androst-1,3,5(10),6-tetraene.
    Type: Grant
    Filed: March 25, 2006
    Date of Patent: March 22, 2011
    Assignee: Harbor Biosciences, Inc.
    Inventor: James M. Frincke
  • Patent number: 7906149
    Abstract: A method for treating oleoresin induced allergic dermatitis by topically contacting an affected area with a therapeutically effective amount of one or more biopolymers for a sufficient amount of time to enable the one or more biopolymers to have an effect and removing the one or more biopolymers from the affected area. The oleoresin can be urushiol, isosolenopsin A, or a combination thereof. The one or more biopolymer can be albumin. The one or more biopolymers can provide a localized anti-inflammatory effect.
    Type: Grant
    Filed: May 25, 2007
    Date of Patent: March 15, 2011
    Assignee: Boval Company, L.P.
    Inventor: Cody L. Yarborough
  • Patent number: 7879359
    Abstract: Compositions for preparing external carbon dioxide agents comprising a granular material containing a water-soluble acid(s), a thickener(s) and a water-soluble dispersant(s) as the essential components wherein the thickener(s) is (are) mixed with the water-soluble acid(s) and the water-soluble dispersant(s), and a viscous material, which consists of a carbonate(s), water and a thickener(s) as essential components; to be mixed with the said granular material at use, by which an external carbon dioxide agent can be prepared easily in a short period of time. The prepared external carbon dioxide agent, containing much carbon dioxide evenly all over, has sufficient viscosity and can form a coating film on the surface in contact with air, therefore the diffusion of carbon dioxide is suppressed, the applied agent does not droop and its thickness is not reduced when applied to skin or mucosa; and the agent shows potent and quick cosmetic and medical effects.
    Type: Grant
    Filed: April 5, 2002
    Date of Patent: February 1, 2011
    Assignee: Neochemir Inc.
    Inventor: Masaya Tanaka
  • Patent number: 7872051
    Abstract: The use of p-menthane-3,8-diol (PMD) in the manufacture of a medicament for use as an antiviral agent. The use of PMD in the manufacture of a medicament to destroy or inactivate viruses. The use of PMD, in vitro, as an antiviral or virucidal agent. The use of PMD in the manufacture of a medicament for the treatment of diseases caused by viruses having a lipid envelope. A face mask comprising at least one protective layer impregnated or sprayed with PMD.
    Type: Grant
    Filed: March 2, 2005
    Date of Patent: January 18, 2011
    Inventor: Paul Douglas Clarke
  • Patent number: 7867948
    Abstract: Physiological strengthening agents in the form of nutritional supplements, feed additives or in cosmetic preparations in the non-medicinal field of application, as well as plant stimulating agents is the use of guanidine compounds of the general formula (I) or their salts, especially creatinol, creatinol-O-phosphate or one of their salts with aspartic acid, ascorbic acid, succinic acid, fumaric acid, acetic acid or phosphoric acid. R1 and R2 can be organic or inorganic compounds, such as, phosphate, sulfate, acetyl, formyl, methyl, ethyl or propyl. The compounds are as nutritional supplements for, e.g., human being in the fields of education, sports, reconvalescence or geriatrics They can also be used as animal feed additives.
    Type: Grant
    Filed: November 16, 2004
    Date of Patent: January 11, 2011
    Assignee: Alzchem Trostberg GmbH
    Inventors: Thomas Gastner, Hans-Peter Krimmer, Thomas Güthner, Werner Sturm
  • Patent number: 7858104
    Abstract: A foundation composition in the form of a water-in-oil emulsion comprising a fatty phase; an aqueous phase; at least one silicone surfacant chosen from C8-C22 alkyl dimethicone copolyols; and at least 5% by weight, relative to the total weight of the composition, of hydrophobic coated pigments; provided that the composition is free of polyglyceryl-4 isostearate or comprises polyglyceryl-4 isostearate in a quantity such that the weight ratio of the C8-C22 alkyl dimethicone copolyol to the polyglyceryl-4 isostearate is greater than or equal to 2:1, wherein the foundation composition can exhibit good stability at room temperature and can be easy to apply to the skin.
    Type: Grant
    Filed: May 1, 2003
    Date of Patent: December 28, 2010
    Assignee: L'Oreal S.A.
    Inventors: Jean-Thierry Simonnet, Aurore Verloo, Emmanuelle Ozee
  • Patent number: 7842646
    Abstract: A synergistic herbicidal mixture comprising A) at least one compound of the formula I wherein R1, R3 are hydrogen, halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, alkylsulfinyl or alkylsulfinyl; R2 is optionally substituted thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, 4,5-dihydroisoxazol-3-yl; R4 is hydrogen, halogen or alkyl; R5 is alkyl; R6 is hydrogen or alkyl; or one of its environmentally compatible salts; and B) a synergistically effective amount of at least one herbicidal compound from the group of ACC inhibitors, ALS inhibitors, amides, aixin herbicides, auxin transport inhibitors, carotenoid biosynthesis inhibitors, ESPS inhibitors, glutamine synthetase inhibitors, lipid biosynthesis inhibitors, mitosis inhibitors, protoporphyrinogen IX oxidase inhibitors, photosynthesis inhibitors, synergists, growth substances, cell wall biosynthesis inhibitors and a variety of other herbicides.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: November 30, 2010
    Assignee: BASF SE
    Inventors: Bernd Sievernich, Max Landes, Elmar Kibler, Wolfgang von Deyn, Helmut Walter, Martina Otten, Karl-Otto Westphalen, Herve Vantieghem
  • Patent number: 7829499
    Abstract: The invention aims at providing a granular pesticide preparation which can be prepared by a simple and easy process and attain optimum controlled-release of pesticidal active ingredients and which is reduced in environmental load and in sufferings induced by pesticidal active ingredients and exerts stable drug effects. The invention relates to a granular pesticide preparation which consists of both non-disintegrating pesticide granules comprising an acid pesticidal active ingredient, a cationic surfactant, and a basic substance and causing no disintegration in water within 30 minutes and a pesticidal active ingredient and which has a particle size of 0.3 to 3 mm in diameter or of 0.6 to 3 mm in breadth and 2 to 10 mm in length and the property of falling into water after the application on water surface and disintegrating in water within 30 minutes.
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: November 9, 2010
    Assignee: Kumiai Chemical Industry Co., Ltd.
    Inventors: Hayase Yamashita, Kiyotoshi Nishiyama, Tetsuo Ohkawa
  • Patent number: 7795178
    Abstract: The present invention relates to a novel active compound combination that is highly suitable for controlling phytopathogenic fungi which contains the known 8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine (spiroxamine) and other known active compounds.
    Type: Grant
    Filed: October 19, 2004
    Date of Patent: September 14, 2010
    Assignee: Bayer CropScience AG
    Inventors: Astrid Mauler-Machnik, Friedrich Kerz-Möhlendick, Stefan Dutzmann, Peter Dahmen
  • Patent number: 7776846
    Abstract: Methods and compositions for enhancing the activity and/or duration of action of soft anti-inflammatory steroids of the haloalkyl 17?-alkoxy-11?-hydroxyandrost-4-en-3-one-17?-carboxylate type and the corresponding ?1,4 compounds and of anti-inflammatory steroids of the hydrocortisone and prednisolone type are described. The enhancing agents have the formula: wherein R is H or C1-C4 alkyl; Z1 is carbonyl or ?-hydroxymethylene; X1 is —O— or —S—; R5 is —OH, —OR6, —OCOOR6 or —OCOR7 wherein R6 is C1-C4 alkyl and R7 is C1-C4 alkyl, fluoromethyl or chloromethyl; and the dotted line in ring A indicates that the 1,2-linkage is saturated or unsaturated; with the proviso that when R is C1-C4 alkyl, then R5 is —OH.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: August 17, 2010
    Inventor: Nicholas S. Bodor
  • Patent number: 7741245
    Abstract: The present invention generally relates to a method of treating plants or plant parts comprising the step of contacting said plants or plant parts with at least one composition comprising at least one double bond adducted cyclopropene compound.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: June 22, 2010
    Assignee: Rohm and Haas Company
    Inventors: Richard Martin Jacobson, Martha Jean Kelly, Fiona Linette Wehmeyer
  • Patent number: 7736630
    Abstract: The present invention relates to novel cosmetic and/or dermatological compounds and compositions for the photoprotection of human skin and/or hair against the damaging effects of UV radiation, in particular solar radiation. In another embodiment the invention relates to compositions and compounds for topical application comprising at least one photoprotective compound for topical application comprising of hydroxylated derivatives of natural Jojoba wax/oil or its synthetic substitute, esterified with carboxylic acids or aminoacids bearing UV-absorbing groups.
    Type: Grant
    Filed: March 26, 2002
    Date of Patent: June 15, 2010
    Inventors: Elka Touitou, Lev Bergelson
  • Patent number: 7718571
    Abstract: The invention provides a method wherein a treating solution containing a compound (A) of specific structure having a C10 to C22 hydrocarbon group at a concentration of 1 to 1000 ppm is applied at least once in a period of from germination of a fruit vegetable to planting in a field and applied at least once after planting in the field.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: May 18, 2010
    Assignee: Kao Corporation
    Inventors: Takayuki Nomura, Masatoshi Kamei, Toshio Hayashi
  • Patent number: 7678834
    Abstract: 4-aminocyclohexanol compounds, processes for their preparation, pharmaceutical formulations comprising these compounds and the use of substituted 4-aminocyclohexanol compounds for the preparation of pharmaceutical formulations and for the treatment of diverse indications, including, without limitation, pain.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: March 16, 2010
    Assignee: Gruenenthal GmbH
    Inventors: Bernd Sundermann, Hagen-Heinrich Hennies, Babette-Yvonne Koegel, Stephan Wnendt
  • Patent number: 7605179
    Abstract: Provided are napthoquinone-type compounds which can be used to modulate the aggregation of protein (e.g. tau) associated with neurodegenerative disease (e.g. Alzheimer's disease). Structure-function characteristics for oxidised and reduced napthoquinone-type compounds, such as menadione-related compounds, are disclosed. The invention further provides methods of treatment or prophylaxis of neurodegenerative diseases and/or clinical dementias based on the compounds.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: October 20, 2009
    Assignee: Wista Laboratories Ltd.
    Inventors: Claude Michel Wischik, David Horsley, Janet Elizabeth Rickard, Charles Robert Harrington
  • Patent number: 7601673
    Abstract: Fungicidal mixtures, comprising, as active components, 1) a sulfamoyl compound of the formula I, ?in which the substituents are as defined below: R1 is hydrogen, halogen, cyano, alkyl, haloalkyl, alkoxy, alkylthio, alkoxycarbonyl, phenyl, benzyl, formyl or CH?NOA; A is hydrogen, alkyl, alkylcarbonyl; R2 is hydrogen, halogen, cyano, alkyl, haloalkyl, alkoxycarbonyl; R3 is halogen, cyano, nitro, alkyl, haloalkyl, alkoxy, alkylthio, alkoxycarbonyl, formyl or CH?NOA; n is 0, 1, 2, 3 or 4; R4 is hydrogen, halogen, cyano, alkyl or haloalkyl; and 2) at least one active compound selected from the following groups: A) azoles; B) strobilurins; C) acylalanines; D) amine derivatives; E) anilinopyrimidines; F) dicarboximides; G) cinnamides and analogs; H) dithiocarbamates; I) heterocylic compounds; K) sulfur and copper fungicides; L) nitrophenyl derivatives; M) phenylpyrroles; N) sulfenic acid derivatives; O) other fungicides; according to the description; in a synergistically effective amount, methods for
    Type: Grant
    Filed: April 23, 2005
    Date of Patent: October 13, 2009
    Assignee: BASF Aktiengesellschaft
    Inventors: Jordi Tormo I Blasco, Thomas Grote, Maria Scherer, Reinhard Stierl, Siegfried Strathmann, Ulrich Schöfl, Markus Gewehr, Bernd Müller, Miguel Octavio Suarez-Cervieri, Matthias Niedenbrück
  • Patent number: 7598206
    Abstract: Fungicidal mixtures, comprising as active components 1) the isoxazole derivative of the formula I, and 2) at least one active compound II selected from the group of the azoles, strobilurins, carboxamides, heterocyclic compounds, carbamates, guanidines, antibiotics, nitrophenyl derivatives, sulfur-containing heterocyclyl compounds, organometallic compounds, organophosphorus compounds, organochlorine compounds, inorganic active compounds, cyflufenamid, cymoxanil, dimethirimol, ethirimol, furalaxyl, metrafenone and spiroxamine, in a synergistically effective amount, methods for controlling harmful fungi using mixtures of the compound I with active compounds II, the use of the compound I with active compounds II for preparing such mixtures and compositions comprising these mixtures.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: October 6, 2009
    Assignee: BASF Aktiengesellschaft
    Inventors: Markus Gewehr, Reinhard Stierl, Matthias Niedenbrück, Udo Hünger
  • Patent number: 7579301
    Abstract: What is described are herbicidal compositions comprising herbicidal compounds of the formula I and a compound which acts as safener. In the formula I, the symbols R1 to R4 denote hydrogen, halogen, alkyl and haloalkyl.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: August 25, 2009
    Assignee: Bayer CropScience AG
    Inventors: Monika H. Schmitt, Lothar Willms, Frank Ziemer, Christopher Rosinger, Hermann Bieringer, Philipp Huff, Erwin Hacker
  • Patent number: 7575739
    Abstract: The present invention is related to a foamable composition of matter comprising iodine, water, a foam adjuvant, a surface-active agent and a gelling agent. This foamable composition, which may be provided in a propellant free foaming device, or alternatively may further comprise a propellant, evolves into foam, which is effective in the topical treatment and prevention of various skin disorders.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: August 18, 2009
    Assignee: Foamix Ltd.
    Inventors: Dov Tamarkin, Doron Friedman, Meir Eini
  • Patent number: 7494955
    Abstract: Tobacco mild green mosaic virus (TMGMV) induces a lethal, systemic, hypersensitive response in Tropical Soda Apple (TSA). This response could be used to kill TSA. TMGMV could be developed and used as a bioherbicide to control TSA. TMGMV is a member of the tobamoviruses, which consist of mechanically transmitted, rod-shaped, RNA viruses that are strictly plant pathogens.
    Type: Grant
    Filed: January 8, 2004
    Date of Patent: February 24, 2009
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Raghavan Charudattan, Matthew Scott Pettersen, Ernest Hiebert